Olumiant (baricitinib) - Eli Lilly
BIO-AD: Microbiome in Atopic Dermatitis Under Systemic Therapy (clinicaltrials.gov) - Oct 23, 2026 - P=N/A | N=600 | Recruiting | Sponsor: Charite University, Berlin, Germany | Trial completion date: Dec 2025 ➔ Dec 2026 | Trial primary completion date: Dec 2025 ➔ Dec 2026 
Trial completion date • Trial primary completion date • Atopic Dermatitis • Dermatitis • Dermatology • Immunology
http://clinicaltrials.gov/ct2/show/NCT05099315
 
Oct 23, 2026
 
Prev Next